AGL 40.05 Increased By ▲ 0.05 (0.13%)
AIRLINK 129.99 Increased By ▲ 0.46 (0.36%)
BOP 6.72 Increased By ▲ 0.04 (0.6%)
CNERGY 4.46 Decreased By ▼ -0.17 (-3.67%)
DCL 8.62 Decreased By ▼ -0.32 (-3.58%)
DFML 40.75 Decreased By ▼ -0.94 (-2.25%)
DGKC 81.39 Decreased By ▼ -2.38 (-2.84%)
FCCL 32.75 Decreased By ▼ -0.02 (-0.06%)
FFBL 75.51 Increased By ▲ 0.04 (0.05%)
FFL 11.67 Increased By ▲ 0.20 (1.74%)
HUBC 109.40 Decreased By ▼ -1.15 (-1.04%)
HUMNL 13.95 Decreased By ▼ -0.61 (-4.19%)
KEL 5.37 Decreased By ▼ -0.02 (-0.37%)
KOSM 7.99 Decreased By ▼ -0.41 (-4.88%)
MLCF 38.89 Decreased By ▼ -0.90 (-2.26%)
NBP 63.51 Increased By ▲ 3.22 (5.34%)
OGDC 196.10 Decreased By ▼ -3.56 (-1.78%)
PAEL 25.88 Decreased By ▼ -0.77 (-2.89%)
PIBTL 7.42 Decreased By ▼ -0.24 (-3.13%)
PPL 156.45 Decreased By ▼ -1.47 (-0.93%)
PRL 25.80 Decreased By ▼ -0.93 (-3.48%)
PTC 17.54 Decreased By ▼ -0.92 (-4.98%)
SEARL 78.80 Decreased By ▼ -3.64 (-4.42%)
TELE 7.88 Decreased By ▼ -0.43 (-5.17%)
TOMCL 33.60 Decreased By ▼ -0.91 (-2.64%)
TPLP 8.55 Decreased By ▼ -0.51 (-5.63%)
TREET 16.60 Decreased By ▼ -0.87 (-4.98%)
TRG 58.03 Decreased By ▼ -3.29 (-5.37%)
UNITY 27.64 Increased By ▲ 0.21 (0.77%)
WTL 1.39 Increased By ▲ 0.01 (0.72%)
BR100 10,514 Increased By 107.8 (1.04%)
BR30 31,342 Decreased By -371.5 (-1.17%)
KSE100 98,008 Increased By 680 (0.7%)
KSE30 30,547 Increased By 354.1 (1.17%)

Pfizer voiced hope Thursday it could roll out up to 20 million doses of a COVID-19 vaccine it is developing with German firm Biontech for emergency use by the end of 2020Pfizer.

The two companies are working on four possible vaccines against the new coronavirus, and launched clinical trials using volunteers in Germany earlier this month.

The head of the US pharma giant's vaccines unit, Nanette Cocero, told a virtual briefing Thursday that the companies were moving forward to ramp up clinical trials and manufacturing capabilities in parallel to be able to produce a large number of doses as soon as a vaccine is demonstrated to be safe and efficient.

It can take years for a new vaccine to be licensed for general use, but in the face of the COVID-19 pandemic, experimental vaccines shown to be safe and effective against the novel coronavirus could likely win approval for emergency use. The virus, which first surfaced in China late last year, has killed nearly 230,000 people and infected close to 3.2 million worldwide, according to a tally from official sources compiled by AFP.

Copyright Agence France-Presse, 2020

Comments

Comments are closed.